Allogene Therapeutics Cash Flow Statement (2019-2025) | ALLO

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -31.54M-41.20M-50.73M-61.05M-54.48M-60.97M-66.20M-68.57M-33.20M-70.52M-77.28M1.89M-79.52M-76.30M-81.51M-93.64M-97.03M-76.76M-56.79M-78.84M-64.07M-66.44M-65.17M-57.54M-59.83M-50.90M-41.32M
Depreciation and Depletion 0.54M1.00M1.18M1.70M1.89M1.89M1.81M1.84M1.92M1.96M2.33M4.24M3.69M3.67M3.86M3.07M3.51M3.64M3.57M3.48M3.56M
Share-based Compensation 7.87M11.49M12.84M13.87M14.21M16.77M17.82M16.45M16.79M21.13M20.86M22.04M22.32M22.89M21.15M17.25M18.77M16.59M15.35M15.23M11.92M13.56M13.39M12.87M12.18M8.69M8.65M
Deferred Taxes -0.05M-0.16M0.03M
Gains from Investment Securities 0.19M1.80M0.87M10.96M0.06M-2.52M0.48M1.94M15.94M4.14M3.11M28.25M-0.04M0.10M2.94M4.00M2.41M-6.00M-0.69M-0.42M1.93M-0.32M
Asset Writedowns and Impairment 13.24M10.73M
Non-cash Items 3.69M
Cash from Operations -30.26M-24.89M-31.93M-50.27M-40.81M-26.72M-37.59M-9.97M-49.33M-41.17M-48.88M-45.44M-68.24M-42.53M-47.66M-62.10M-66.64M-61.86M-55.53M-53.71M-55.90M-63.59M-44.12M-36.70M-52.93M-39.03M-29.69M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.22M1.06M0.85M0.46M0.21M-0.06M-1.59M-1.81M-1.91M-1.83M-1.61M-1.59M-1.33M-0.91M-0.49M-0.16M-0.51M1.07M2.94M3.30M2.80M2.20M1.70M1.65M1.31M1.17M0.92M
Depreciation & Amortization (CF) 0.54M1.00M1.18M1.70M1.89M1.89M1.81M1.84M1.92M1.96M2.33M4.24M3.69M3.67M3.86M3.07M3.51M3.64M3.57M3.48M3.56M3.64M3.21M3.23M3.10M3.11M3.10M
Change in Working Capital
Change in Account Payables -0.35M1.68M-4.47M2.15M-1.04M0.54M2.18M-1.07M4.15M-3.06M0.19M-2.04M-0.51M1.42M1.01M2.94M1.06M-4.29M-3.97M-0.30M-0.12M6.81M-7.23M0.03M-0.34M-0.42M-1.07M
Change in Accured Expenses -4.09M3.99M7.62M-1.16M-3.91M10.74M9.35M2.55M-4.31M1.84M8.89M-2.77M-9.05M5.71M1.95M3.14M5.69M-0.08M-12.72M0.29M-5.69M-0.98M2.53M2.88M-5.22M1.74M1.09M
Investing Activities
Capital Expenditures 10.42M7.86M18.40M14.11M12.25M16.05M20.25M17.40M8.30M9.06M3.35M0.74M1.90M1.37M0.22M1.69M1.03M0.29M0.01M0.18M0.01M0.43M0.26M0.10M0.12M0.17M
Change in Acquisitions & Divestments 95.71M101.71M158.35M116.81M120.26M101.37M150.14M221.85M268.25M215.82M161.78M82.54M68.68M117.12M74.58M99.08M143.44M152.87M165.16M136.34M103.27M117.22M109.80M102.17M56.50M53.80M61.91M
Cash from Investing Activities 32.89M44.49M78.78M7.93M-15.01M-428.97M-83.36M22.21M96.80M24.59M13.01M29.25M-22.38M54.03M24.91M49.60M112.94M17.16M-34.27M67.46M22.13M74.61M-75.99M54.93M6.18M43.84M11.94M
Financing Activities
Other financing activities 2.28M3.35M3.56M
Change in Capital Stock
Shares Issued 0.68M1.10M1.18M1.44M3.34M2.41M588.54M4.06M3.21M0.75M0.32M1.53M-0.00M0.93M1.73M0.77M0.86M0.68M10.00M-9.36M0.26M
Misc.
Cash from Financing Activities 0.68M0.24M1.57M56.47M16.59M600.17M3.85M12.98M6.04M3.21M2.38M0.32M1.81M0.02M1.07M0.05M1.73M89.52M4.29M0.15M1.65M108.60M0.68M5.74M13.99M5.07M3.24M
Change in Cash 3.32M19.84M48.41M14.14M-39.23M144.48M-117.09M25.21M53.51M-13.36M-33.48M-15.86M-88.80M11.53M-21.68M-12.45M48.03M44.83M-85.51M13.91M-32.12M119.63M-119.43M23.98M-32.76M9.88M-14.52M
Beginning Cash Balance 677.38M92.75M112.58M160.99M175.13M135.90M275.23M158.14M183.35M236.87M223.50M189.18M173.31M84.51M96.04M74.36M61.90M109.93M154.76M69.25M83.16M51.04M170.67M51.24M75.22M42.45M52.33M
Free Cash Flow -40.68M-32.75M-50.34M-64.38M-53.06M-42.77M-57.84M-27.38M-57.63M-50.23M-52.23M-46.17M-70.14M-43.91M-47.88M-63.79M-67.67M-62.15M-55.54M-53.89M-55.91M-63.59M-44.54M-36.95M-53.03M-39.15M-29.86M
Net Cash Flow 3.32M19.84M48.41M14.14M-39.23M144.48M-117.09M25.21M53.51M-13.36M-33.48M-15.86M-88.80M11.53M-21.68M-12.45M48.03M44.83M-85.51M13.91M-32.12M119.63M-119.43M23.98M-32.76M9.88M-14.52M